Category: Press Release

CGTN:How do stable China-Russia ties contribute to a turbulent world?

BEIJING, May 08, 2025 (GLOBE NEWSWIRE) — A natural gas pipeline that stretches 3,000 kilometers in Russia and 5,111 km in China commenced operations in December last year, benefiting about 450 million people along its route. The China-Russia east-route natural gas pipeline is a landmark project of energy cooperation between the two countries, yet ties […]

Read More

Yili Reports FY2024 Revenue of 115.8 Billion Yuan, Reinforcing Its Position as Asia’s Leading Dairy Company

HOHHOT, China, May 08, 2025 (GLOBE NEWSWIRE) — On April 29, Inner Mongolia Yili Industrial Group Co., Ltd. (600887.SH) released its financial results, reporting total revenue of 115.78 billion yuan in FY2024, further solidifying its position as Asia’s top dairy producer. In the first quarter of FY2025, Yili delivered better-than-expected growth, achieving simultaneous increases in both […]

Read More

EAACI Hong Kong Allergy School 2025: A Landmark in Global Allergy Education

ZURICH, May 08, 2025 (GLOBE NEWSWIRE) — The European Academy of Allergy & Clinical Immunology (EAACI), in partnership with the Hong Kong Institute of Allergy (HKIA), is proud to announce the inaugural EAACI Hong Kong Allergy School. This significant milestone will unfold in Hong Kong – Asia’s World City – a dynamic hub where East […]

Read More

Zoom and ServiceNow Announce Strategic Integration to Elevate Customer and Employee Experiences

Unified Engagement from Zoom CX and ServiceNow integrates voice, video, and digital channels directly within the ServiceNow AI Platform for a simpler agent experience and more personalized customer engagements LAS VEGAS, May 07, 2025 (GLOBE NEWSWIRE) — Zoom Communications Inc. (NASDAQ: ZM) and ServiceNow (NYSE: NOW), the AI platform for business transformation, today announced plans […]

Read More

Dr. Falk Pharma announces positive results from its pivotal phase 3 trial on norucholic acid in primary sclerosing cholangitis

Freiburg, May 7th, 2025 Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat primary sclerosing cholangitis. The results of the 96-week analysis of the NUC-5 trial will be presented at 2025 EASL Congress in Amsterdam. Dr. Falk Pharma, a research-based pharmaceutical […]

Read More

Recent Posts

Yaadga Region Leaders Gather to Address Development Challenges

Ouahigouya:More than 90 individuals from the Lorum province convened in Ouahigouya for the Day of cadres and skills of the Yaadga region. This event, chaired by Thomas Yampa, Governor of the Yaadga region, focused on addressing regional development ch…